Adicet Bio (ACET) EBT (2017 - 2026)

Adicet Bio has reported EBT for 10 years, with the latest figure at -$21.2 million in Q2 2026.

• On a quarterly basis, EBT rose 32.04% year-over-year to -$21.2 million in Q2 2026; TTM through Jun 2026 was -$98.8 million, a 16.69% increase from a year earlier, with the FY2025 full-year figure at -$116.8 million, changed 0.27% from the prior year.
• EBT was -$21.2 million for Q2 2026 at Adicet Bio, down from -$20.2 million in the prior quarter.
• The five-year high for EBT was $4.6 million in Q1 2022, with the low at -$49.9 million in Q3 2023.
• Average EBT over 5 years is -$27.1 million, with a median of -$29.1 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT soared 121.61% in 2022, then sank 768.71% in 2023.
• Over 5 years, EBT stood at -$29.9 million in 2022, then gained by 1.29% to -$29.5 million in 2023, then gained by 2.58% to -$28.7 million in 2024, then decreased by 6.23% to -$30.5 million in 2025, then soared by 30.48% to -$21.2 million in 2026.
• The last three EBT figures came in at -$21.2 million (Q2 2026), -$20.2 million (Q1 2026), and -$30.5 million (Q4 2025), per Business Quant data.